Beikabuzukan
日本語
Watchlist

Universe Pharmaceuticals Inc.

Overview

Financials

Units: $M (per-share in $, ratios in %)

Revenue & profit

Margins

Valuation

Multiples at each fiscal year end (annual) and current (TTM)

Valuation history

Segments

Revenue breakdown (annual, $B). Segments depend on each year’s disclosure.

By product

By region

Dividends & earnings

Annual dividend per share ($, split-adjusted)

EPS (diluted), last 16 quarters ($)

Company info

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.